Canada Life’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $234M | Sell |
1,675,983
-8,858
| -0.5% | -$1.24M | 0.42% | 39 |
|
|
2025
Q4 | $207M | Sell |
1,684,841
-570,987
| -25% | -$69.4M | 0.36% | 47 |
|
|
2025
Q3 | $254M | Buy |
2,255,828
+28,270
| +1% | +$3.21M | 0.36% | 46 |
|
|
2025
Q2 | $247M | Buy |
2,227,558
+31,793
| +1% | +$3.38M | 0.39% | 43 |
|
|
2025
Q1 | $246M | Buy |
2,195,765
+99,101
| +5% | +$10.2M | 0.43% | 37 |
|
|
2024
Q4 | $194M | Sell |
2,096,664
-72,343
| -3% | -$6.51M | 0.33% | 53 |
|
|
2024
Q3 | $182M | Buy |
2,169,007
+36,966
| +2% | +$2.82M | 0.32% | 54 |
|
|
2024
Q2 | $146M | Buy |
2,132,041
+323,005
| +18% | +$21.6M | 0.28% | 65 |
|
|
2024
Q1 | $133M | Buy |
1,809,036
+21,224
| +1% | +$1.63M | 0.27% | 69 |
|
|
2023
Q4 | $144M | Sell |
1,787,812
-29,436
| -2% | -$2.29M | 0.32% | 61 |
|
|
2023
Q3 | $136M | Buy |
1,817,248
+6,694
| +0.4% | +$515K | 0.33% | 58 |
|
|
2023
Q2 | $140M | Buy |
1,810,554
+191,686
| +12% | +$15.3M | 0.33% | 57 |
|
|
2023
Q1 | $135M | Buy |
1,618,868
+45,794
| +3% | +$3.79M | 0.33% | 58 |
|
|
2022
Q4 | $136M | Sell |
1,573,074
-401,689
| -20% | -$31.8M | 0.36% | 54 |
|
|
2022
Q3 | $122M | Sell |
1,974,763
-33,544
| -2% | -$2.12M | 0.35% | 55 |
|
|
2022
Q2 | $124M | Sell |
2,008,307
-20,231
| -1% | -$1.25M | 0.33% | 61 |
|
|
2022
Q1 | $127M | Buy |
2,028,538
+111,090
| +6% | +$7.1M | 0.27% | 72 |
|
|
2021
Q4 | $139M | Buy |
1,917,448
+204,648
| +12% | +$14.1M | 0.29% | 65 |
|
|
2021
Q3 | $120M | Buy |
1,712,800
+23,984
| +1% | +$1.68M | 0.28% | 66 |
|
|
2021
Q2 | $116M | Sell |
1,688,816
-150,416
| -8% | -$10M | 0.27% | 73 |
|
|
2021
Q1 | $118M | Sell |
1,839,232
-342,908
| -16% | -$22.1M | 0.29% | 69 |
|
|
2020
Q4 | $127M | Buy |
2,182,140
+104,971
| +5% | +$6.33M | 0.24% | 97 |
|
|
2020
Q3 | $131M | Sell |
2,077,169
-3,363
| -0.2% | -$233K | 0.29% | 88 |
|
|
2020
Q2 | $160M | Sell |
2,080,532
-109,754
| -5% | -$8.41M | 0.37% | 67 |
|
|
2020
Q1 | $165M | Buy |
2,190,286
+15,861
| +0.7% | +$1.1M | 0.44% | 53 |
|
|
2019
Q4 | $140M | Buy |
2,174,425
+315,662
| +17% | +$20.6M | 0.31% | 76 |
|
|
2019
Q3 | $118M | Buy |
1,858,763
+45,394
| +3% | +$2.97M | 0.28% | 85 |
|
|
2019
Q2 | $122M | Sell |
1,813,369
-6,116
| -0.3% | -$402K | 0.28% | 82 |
|
|
2019
Q1 | $118M | Buy |
1,819,485
+181,393
| +11% | +$12.1M | 0.31% | 79 |
|
|
2018
Q4 | $99.1M | Sell |
1,638,092
-270,402
| -14% | -$18.9M | 0.28% | 81 |
|
|
2018
Q3 | $148M | Sell |
1,908,494
-133,568
| -7% | -$10.1M | 0.35% | 65 |
|
|
2018
Q2 | $145M | Buy |
2,042,062
+100,519
| +5% | +$7.1M | 0.34% | 65 |
|
|
2018
Q1 | $147M | Sell |
1,941,543
-36,198
| -2% | -$2.88M | 0.35% | 64 |
|
|
2017
Q4 | $141M | Buy |
1,977,741
+141,241
| +8% | +$10.7M | 0.33% | 70 |
|
|
2017
Q3 | $148M | Buy |
1,836,500
+67,664
| +4% | +$5.17M | 0.37% | 65 |
|
|
2017
Q2 | $125M | Buy |
1,768,836
+96,802
| +6% | +$6.44M | 0.33% | 68 |
|
|
2017
Q1 | $113M | Sell |
1,672,034
-43,819
| -3% | -$3.08M | 0.31% | 68 |
|
|
2016
Q4 | $123M | Buy |
1,715,853
+133,741
| +8% | +$9.94M | 0.35% | 62 |
|
|
2016
Q3 | $125M | Buy |
1,582,112
+30,741
| +2% | +$2.5M | 0.36% | 60 |
|
|
2016
Q2 | $129M | Buy |
1,551,371
+253,457
| +20% | +$22.5M | 0.39% | 59 |
|
|
2016
Q1 | $119M | Buy |
1,297,914
+14,656
| +1% | +$1.32M | 0.43% | 55 |
|
|
2015
Q4 | $130M | Buy |
1,283,258
+18,958
| +1% | +$1.97M | 0.5% | 45 |
|
|
2015
Q3 | $124M | Buy |
1,264,300
+196,515
| +18% | +$21.8M | 0.49% | 44 |
|
|
2015
Q2 | $125M | Buy |
1,067,785
+46,073
| +5% | +$5.03M | 0.43% | 53 |
|
|
2015
Q1 | $100M | Sell |
1,021,712
-41,453
| -4% | -$4.21M | 0.34% | 71 |
|
|
2014
Q4 | $100M | Sell |
1,063,165
-315,962
| -23% | -$32.7M | 0.33% | 71 |
|
|
2014
Q3 | $147M | Sell |
1,379,127
-60,420
| -4% | -$5.92M | 0.49% | 43 |
|
|
2014
Q2 | $119M | Sell |
1,439,547
-188,840
| -12% | -$14.7M | 0.39% | 55 |
|
|
2014
Q1 | $115M | Buy |
1,628,387
+356,093
| +28% | +$27.9M | 0.4% | 54 |
|
|
2013
Q4 | $96M | Sell |
1,272,294
-16,257
| -1% | -$1.13M | 0.34% | 64 |
|
|
2013
Q3 | $80.8M | Buy |
1,288,551
+821,162
| +176% | +$49.1M | 0.32% | 72 |
|
|
2013
Q2 | $23.9M | Buy |
+467,389
| New | +$24.4M | 0.16% | 121 |
|
Other funds holding GILD
VCM
VPM
Canada Life's GILD Position: Q1 2026 in Review
Canada Life reduced its Gilead Sciences (GILD) stake by 0.53% in Q1 2026, selling an estimated $1.24M and leaving 1,675,983 shares worth $234M. The position accounts for 0.42% of the portfolio, ranked #39.
Canada Life first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $254M in Q3 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Canada Life held 1,675,983 shares of Gilead Sciences worth $234M as of Q1 2026.
- Canada Life sold 8,858 Gilead Sciences shares in Q1 2026, an estimated $1.24M.
- Gilead Sciences made up 0.42% of Canada Life's portfolio in Q1 2026, its #39 holding.
- Canada Life first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Canada Life's Gilead Sciences position peaked at $254M in Q3 2025.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.